Israeli drugmaker Teva and Japan's Takeda have undergone separate, yearslong cutback sprees, looking to slice away a range of underperforming assets. Now, the two drugmakers will take a scalpel to their joint venture in Japan as they continue to hunt for savings.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,